OIG:
J9355 Refund Requests Are on the Rise -- Are Your Herceptin Claims in the Clear?
Published on Thu Mar 14, 2013
Repeating a single mistake can lead to more than $100,000 in overpayments. Herceptin units are under nationwide scrutiny by the Office of Inspector General (OIG). Here’s a look at the mistakes practices are making and the steps you can take to avoid those traps. Focus on Units Actually Administered Herceptin’s indications include treating breast cancer and metastatic gastric cancer, and [...]